Vivus Inc. (VVUS)'s weight-loss pill Qnexa won the backing of a US advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. Advisers to the Food and Drug Administration voted 20-2 today that Qnexa's benefits ... See all stories on this topic »
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment